Skip to content

Nicotine as an Adjuvant Analgesic for Third Molar Surgery

Effect of Nicotine on Pain After Third Molar Extraction.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00385216
Enrollment
20
Registered
2006-10-09
Start date
2004-07-31
Completion date
2009-06-30
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Crowding

Keywords

Third Molar, Pain

Brief summary

Third molar surgery is complicated by pain and swelling for several days after surgery. Non-steroidal antiinflammatory drugs have been useful in combination with opioids for treatment. Nicotine has antiinflammatory and pain relieving properties. We will use nicotine or placebo as a nasal spray before surgery to determine whether nicotine affects pain or inflammation.

Detailed description

This is a randomized double blind cross-over study. In each of two sittings, the third molars on one side of the mouth are removed. In one sitting the subject will receive a nicotine nasal spray (3mg) and in the other placebo. VAS and narcotic utilization will be compared within patients.

Interventions

DRUGNicotine

Nicotine nasal spray 3mg x 1 before surgery

OTHERPlacebo

Placebo nasal spray 0mg x 1 before surgery

Sponsors

Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* over 18 * 4 molars to be removed

Exclusion criteria

* pregnant * lactating * chronic pain * narcotic use * asthma * ex-smokers

Design outcomes

Primary

MeasureTime frameDescription
Pain Reported by PatientUp to 1 dayPain were reported on the numerical rating scale for pain (NRS) with 0=no pain and 10=worst pain.

Secondary

MeasureTime frameDescription
Heart Rate5 daysHeart rate reported in beats per minute (BPM)
Systolic Blood Pressure5 daysSystolic blood pressure reported in Millimeters of Mercury (mmHg)
Diastolic Blood Pressure5 daysDiastolic blood pressure reported in Millimeters of Mercury (mmHg)
Difference in Amount of Nausea Reported5 daysFor an hour postoperatively, subjects reported information on pain and nausea, and hemodynamic variables were recorded at 15-minute intervals. Telephone follow-up was recorded for 5 days postoperatively, where patients reported information on pain, nausea, and use of hydrocodone/acetaminophen as rescue analgesia.
Difference in Number of Hydrocodone 5 mg Acetaminophen 325 mg Tablets Taken After Surgery5 daysAll patients were prescribed Hydrocodone 5 mg / Acetaminophen 325 mg and were instructed to take 1 to 2 tablets for oral pain at a maximum of every 4 to 6 hours post-surgery.

Countries

United States

Participant flow

Participants by arm

ArmCount
Entire Study Population
The baseline characteristics for the entire study population are presented here. The nicotine and placebo study populations were identical.
20
Total20

Baseline characteristics

CharacteristicEntire Study Population
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
20 Participants
Age, Continuous23 years
STANDARD_DEVIATION 5
Region of Enrollment
United States
20 participants
Sex: Female, Male
Female
11 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 200 / 20
serious
Total, serious adverse events
0 / 200 / 20

Outcome results

Primary

Pain Reported by Patient

Pain were reported on the numerical rating scale for pain (NRS) with 0=no pain and 10=worst pain.

Time frame: Up to 1 day

ArmMeasureValue (MEAN)Dispersion
Nicotine Nasal SprayPain Reported by Patient1.6 score on a scaleStandard Deviation 0.5
PlaceboPain Reported by Patient2.9 score on a scaleStandard Deviation 0.5
Secondary

Diastolic Blood Pressure

Diastolic blood pressure reported in Millimeters of Mercury (mmHg)

Time frame: 5 days

ArmMeasureValue (MEAN)Dispersion
Nicotine Nasal SprayDiastolic Blood Pressure77 Millimeters of Mercury (mmHg)Standard Deviation 8
PlaceboDiastolic Blood Pressure76 Millimeters of Mercury (mmHg)Standard Deviation 10
Secondary

Difference in Amount of Nausea Reported

For an hour postoperatively, subjects reported information on pain and nausea, and hemodynamic variables were recorded at 15-minute intervals. Telephone follow-up was recorded for 5 days postoperatively, where patients reported information on pain, nausea, and use of hydrocodone/acetaminophen as rescue analgesia.

Time frame: 5 days

Population: The difference in the amount of nausea was not calculated. Raw data existed during the study period of 2004 to 2009. This record was completed and published in 2010 without results for this outcome measure. The data was subsequently destroyed because the data retention period had ended. As of the current year, 2024, all the raw data for this study no longer exists. This outcome cannot be calculated without the raw data.

Secondary

Difference in Number of Hydrocodone 5 mg Acetaminophen 325 mg Tablets Taken After Surgery

All patients were prescribed Hydrocodone 5 mg / Acetaminophen 325 mg and were instructed to take 1 to 2 tablets for oral pain at a maximum of every 4 to 6 hours post-surgery.

Time frame: 5 days

Population: The difference in the amount of nausea was not calculated. Raw data existed during the study period of 2004 to 2009. This record was completed and published in 2010 without results for this outcome measure. The data was subsequently destroyed because the data retention period had ended. As of the current year, 2024, all the raw data for this study no longer exists. This outcome cannot be calculated without the raw data.

Secondary

Heart Rate

Heart rate reported in beats per minute (BPM)

Time frame: 5 days

ArmMeasureValue (MEAN)Dispersion
Nicotine Nasal SprayHeart Rate81 Beats per minute (BPM)Standard Deviation 15
PlaceboHeart Rate76 Beats per minute (BPM)Standard Deviation 15
Secondary

Systolic Blood Pressure

Systolic blood pressure reported in Millimeters of Mercury (mmHg)

Time frame: 5 days

ArmMeasureValue (MEAN)Dispersion
Nicotine Nasal SpraySystolic Blood Pressure120 Millimeters of Mercury (mmHg)Standard Deviation 11
PlaceboSystolic Blood Pressure121 Millimeters of Mercury (mmHg)Standard Deviation 12

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026